JAMA Psychiatry. 2021;78(9):1013-1019. doi:10.1001/jamapsychiatry.2021.1471

Question:  Has the population-attributable risk fraction for cannabis use disorder in schizophrenia increased over time, as would be expected with increasing use and potency of cannabis?

Findings: In this Danish nationwide, register-based cohort study, the population-attributable risk fraction for cannabis use disorder in schizophrenia increased from approximately 2% in the period to 1995 to approximately 6% to 8% since 2010.

Meaning: These findings may indicate that cannabis use disorders are associated with an increase in the proportion of cases of schizophrenia.

Abstract

Importance:  Cannabis use and potency of cannabis have increased during the past 2 decades. If the association between cannabis use and schizophrenia is causal, this should be reflected in an increase in the proportion of cases of schizophrenia being attributable to cannabis, the population-attributable risk fraction (PARF).

Objective: To determine whether the PARF for cannabis use disorder in schizophrenia has increased over time.

Exposure:  Diagnosis of cannabis use disorder.

Main Outcomes and Measures:  Diagnosis of schizophrenia, with estimated PARF of cannabis use disorder in schizophrenia from 1972 to 2016.

Results:  A total of 7 186 834 individuals were included in the analysis, including 3 595 910 women (50.0%) and 3 590 924 men (50.0%). The adjusted hazard ratio for schizophrenia fluctuated at approximately 4 (with 95% CIs ranging from approximately 3 to 6) throughout most of the study period when people diagnosed with cannabis use disorder were compared with those without cannabis use disorder. The PARF of cannabis use disorder in schizophrenia also fluctuated, but with clear evidence of an increase from 1995 (when the PARF was relatively stable around 2.0%, with a 95% CI of approximately 0.3% to either side) until reaching some stability around 6.0% to 8.0% (with a 95% CI of approximately 0.5% to either side) since 2010.

Conclusions and Relevance:  The results from these longitudinal analyses show the proportion of cases of schizophrenia associated with cannabis use disorder has increased 3- to 4-fold during the past 2 decades, which is expected given previously described increases in the use and potency of cannabis. This finding has important ramifications regarding legalization and control of use of cannabis.

For complete research

 

For more Data on Cannabis impact on Mental Health

All Young Cannabis Users Face Psychosis Risk

Cannabis & Psychosis – irrefutable

Cannabis & Mental Health – Professor Copeland

Does Marijuana Cause Mental Illness?

Do You Think You Know? Does Cannabis Cause Mental Illness?

Cannabis & Psychosis: Understanding risk is of 'vital importance'

This is what you will find on the NoBrainer Website

NoBrainer Education
Find a range of teaching/learning as well as coaching tools for educators of all types. Assisting you to build resilience into your community/school/family setting and better understand best-practice around AOD issues
NoBrainer Resources
Find here a range of resources that you can connect with to help you navigate many of the issues of AOD Use
NoBrainer News
Find out what is happening in the world of alcohol & other drugs, Lots of useful articles for you to read.
NoBrainer Videos
Check out our selection of video clips on various AOD issues to assist you in getting better perspective